Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
236 Leser
Artikel bewerten:
(1)

Ceva Animal Health: Ceva Announces Strategic Leadership Changes In Asia-Pacific And China

LIBOURNE, France, Feb. 9, 2026 /PRNewswire/ -- Ceva Animal Health (Ceva), the world's fifth-largest animal health company operating in 110 countries, is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operational excellence. As part of this strategic realignment, Ceva has relocated its Asia-Pacific regional headquarters to Shanghai, positioning the company to serve the dynamic markets in the region more effectively.

Arnaud Le Boulanger, Executive Vice President APAC & China region

Arnaud Leboulanger is appointed Executive Vice President (EVP) of the new APAC & China region. He joined the group in 2003 and gained solid international experience as a General Manager for entities in South Eastern Europe, the Middle East and the Pacific, before taking over the French, and then the Southern European subsidiaries. Arnaud's track record illustrates his ability to drive change, spearhead transformations, and support sustainable growth. His vision and knowledge of diversified markets will be key assets to support Ceva's ambitions in this strategic region.

Anh-Mai Vu, currently Director of Global E-Commerce, is appointed Head of Pet Products for the APAC & China region. Over the past two years, she has led the digital transformation and developed our global e-commerce division, strengthening the company's presence in several markets. Her leadership and strategic vision will be key to accelerating growth in this high-potential region, focusing on expansion, customer experience and creating new opportunities.

Speaking on this leadership change, Andras Bolcskei, Executive Vice-President, Global Commercial Operations, says: "Today's appointment builds upon the solid foundations established by Arnaud. We sincerely appreciate his leadership and are confident it will continue to guide him successfully in his new role. His ability to deliver results across all species will be a key asset as he steps into this expanded responsibility. We look forward to seeing him drive accelerated growth across APAC and China."

Commenting on his new appointment, Arnaud Leboulanger says: "We are excited to begin this new chapter for Ceva in the Asia Pacific and China region. Relocating our regional headquarters to Shanghai reflects our commitment to being closer to our dynamic and rapidly evolving markets. With a strategic focus on innovation, operational excellence, and customer-centricity, we are well-positioned to accelerate growth and create sustainable value for our customers, partners, and the communities we serve. I look forward to leading our talented teams through this transformation and unlocking the full potential of this vibrant region."

About Ceva Animal Health

Ceva Animal Health (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers.

With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: "Together, beyond animal health".

2025 turnover: €1.92 billion

www.ceva.com

Press contact:

emilie.barrail@ceva.com

Photo - https://mma.prnewswire.com/media/2876852/Ceva_Animal_Health.jpg
Logo - https://mma.prnewswire.com/media/2876851/CEVA_Animal_Health_Logo.jpg

CEVA Animal Health

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ceva-announces-strategic-leadership-changes-in-asia-pacific-and-china-302679262.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.